A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.
Also in this 12-page issue: GM Cancer Research Foundation awards annual prizes to four scientists.
Age-adjusted cancer incidence and mortality down slightly, annual report finds.
Bills in House, Senate, would give FDA authority over tobacco products.
Surgeon General’s report adds to list of smoking-related cancers, other diseases.
ASCO honors physicians for clinical trials participation.
President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.
Funding opportunities listed.
Trending Stories
- Elisa Rodriguez named first chief diversity and equity officer for faculty at Roswell Park
- Nancy Goodman: “Sen. Sanders says he cares about kids with cancer. I’m just asking him to show us.”
- Gregory Curt, Clinician and Drug Developer, Dies at 64
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Otis Brawley looks back on a year of great science and greater challenges
- GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation









